2nd Real-World Evidence Forum

Memo

The Real-World Evidence Forum, taking place on July 16-17, 2018 in Philadelphia, will bring together clinical health professionals to address how to operationalize the process of collecting real-world data. Our expert staff will discuss how to utilize real-world evidence to demonstrate both clinical effectiveness and cost-effectiveness of your product. Attendees will gain a better understanding of how electronic data sources are changing the way real world data is being collected. This conference will offer attendees insight on how real-world evidence will help decrease costs and development timelines, define innovative outcomes, and minimize the number of patients exposed to less useful medications.

URLs:

Tickets: https://go.evvnt.com/225237-1?pid=5569

Brochure: https://go.evvnt.com/225237-2?pid=5569

Booking: https://go.evvnt.com/225237-4?pid=5569



Time: 8:00 am to 5:00 pm



Prices:

Early Bird Pricing — Register by June 8, 2018 : USD 1895.0,

Standard Pricing: USD 2095.0,

Onsite Pricing: USD 2195.0



Speakers: Bart Barefoot Director, VEO and RWE Policy, Advocacy, and External Collaboration, GLAXOSMITHKLINE, Christopher Boone, Ph.D., FACHE Vice President, Real- World Data and Analytics Center of Excellence, Patient and Health Impact, PFIZER, atrick Loerch Sr. Director, Data Sciences, CELGENE CORP, Dr. Jefferson Tea Vice President, Medical and Scientific Affairs, TAKEDA PHARMACEUTICALS



Venue Details: The Inn at Penn, 3600 Sansom Street, Philadelphia, 19104, United States